Press releases, news stories and media library. We at Intelligent Implants are developing breakthrough bioelectronics. Here are some of the most current and up-to-date highlights.
Intelligent Implants is featured on InnovationMap following its successful presentation for demo day at Houston's award-winning medical devices accelerator program , TMCx. The program provides startup companies with shared workspace, a curriculum tailored to the needs of health care entrepreneurs and the guidance of over 200 advisors from the front lines of the industry. Participants develop their companies by attending a variety of workshops and hands-on events to gain insights from experts in every facet of running a health-related business: clinical trials, FDA regulations, HIPAA/HITECH compliance, hospital procurement, commercial pilots, intellectual property, licensing, fundraising, marketing and other critical areas.
Intelligent Implants is selected as Most Promising Life Science Company at the 2018 Texas Life Science Forum hosted by the Rice Alliance and BioHouston. Ten early-stage companies were chosen by investors as the “Rice Alliance Most Promising Life Science Companies” from among those having raised less than $2 million in funding to-date. The Texas Life Science Forum is the premier life science event in Texas that brings together members from industry, emerging life science companies, academic, and investors.
Intelligent Implants is featured on the front page of the business section of the Houston Chronicle. Enterprise reporter Andrea Leinfelder follows the trajectory and success of Intelligent Implants in Houston through its different institutions. The article highlights the nature of the ecosystem that is being built at the Texas Medical Center and how Intelligent Implants has participated in it to grow the company and develop its product.
Intelligent Implants was awarded $250,000 from the $25 million Texas Medical Center (TMC) Venture Fund, supporting early-stage health care companies. The TMC Venture Fund accomplishes one of the key tenets of the Texas Medical Center’s strategic plan by transforming innovative ideas into tangible solutions for improving health. The fund provides monetary resources to young startups in the health care space with a nexus to Houston and the Texas Medical Center. These early, but critical-stage investments heighten companies’ chances of receiving additional funding and long-term success.
As part of the collaboration with Johnson & Johnson Innovation, the angelMD Catalyst Fund will make a $50,000 investment each in Intelligent Implants. In addition, angelMD will feature Intelligent Implants on its investment platform for angelMD members to invest an additional $350,000 in the company. The investments were officially announced by Charlie Emley, Catalyst Fund Managing Partner, at the 2017 MedTech Conference in San Jose, California.
Intelligent Implants is proud to announce that they are one of the winners in J&J´s global device start-up competition. In conjunction with the Grand Opening of the Center for Device Innovation (CDI @ TMC) in the Fall 2017, Johnson & Johnson Innovation and Johnson & Johnson Medical Devices launched the CDI @ TMC QuickFire Challenge, a device-focused challenge aimed at game-changing early-stage medical device innovations across strategic
CALIN, is a new €12 million life science network to assist Irish and Welsh businesses to innovate by offering open access to a unique strategic international partnership involving 6 world leading higher educational institutions and global healthcare leaders Unilever and GE Healthcare.
With the aid of Johnson and Johnson Innovation, Intelligent Implants has opened its Houston,TX office. The Johnson & Johnson Innovation family of companies (including JLABS) helps companies efficiently access expertise, funding, services and facilities to advance business and science.
Out of 50+ submissions, only 11 most promising start-ups were chosen to showcase their innovations to the Conference attendees, potential business partners and investors.
Enterprise Ireland is the state agency responsible for supporting the development of manufacturing and internationally traded services companies. They provide funding and support for companies - from entrepreneurs with business propositions for a high potential start-up through to large companies expanding their activities. Intelligent Implants has graciously accepted funding support from EI in a collaborative effort to advance our technologies and bring research and industry to Ireland.